
Abjoint AQ 75mg Injection
Marketer
Abendis Lifesciences
Salt Composition
Diclofenac (75mg)
Overview Abjoint AQ 75mg Injection
ArthroSolve 75mg Injection provides analgesia for pain management. Indicated for pain, inflammation, rigidity, and arthritic discomfort associated with conditions such as rheumatoid arthritis, osteoarthritis, and acute trauma to the musculoskeletal system, it's administered parenterally when oral intake is infeasible. Administration must be performed by a qualified medical professional; self-injection is strictly prohibited. Prior history of cardiovascular events (e.g., heart disease, stroke) should be disclosed to your physician. Report any injection site reactions (pain, swelling, erythema) immediately. Common adverse effects include nausea, emesis, cephalalgia, and local injection site responses. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with hematological parameters. Chronic use carries a risk of severe complications, including gastrointestinal hemorrhage and nephropathy.
Uses of Abjoint AQ 75mg Injection
Analgesia
Major Benefits of Abjoint AQ 75mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Abjoint AQ 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Abjoint AQ 75mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Abjoint AQ 75mg Injection works:
Abjoint AQ 75mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use of Abjoint AQ 75mg Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Abjoint AQ 75mg Injection during pregnancy poses a confirmed risk to fetal development, rendering it unsafe. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the inherent hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Administering Abjoint AQ 75mg Injection to breastfeeding individuals is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Abjoint AQ 75mg Injection may result in adverse reactions that could impair driving capabilities.
KidneyCAUTION
Caution is advised when administering Abjoint AQ 75mg Injection to individuals with impaired renal function. Dosage modification of Abjoint AQ 75mg Injection may be necessary; physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Abjoint AQ 75mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Abjoint AQ 75mg Injection :
Omit a dose of Abjoint AQ 75mg Injection? Seek your physician's advice.
Facts to Know About Abjoint AQ 75mg Injection
| Label | Value |
|---|---|
| Type of Compound | Acetic acid phenyl derivative |
| Addictive | None. |
| Medication Classification | Pain relievers |
